` IRIX (IRIDEX Corp) vs S&P 500 Comparison - Alpha Spread

IRIX
vs
S&P 500

Over the past 12 months, IRIX has underperformed S&P 500, delivering a return of -14% compared to S&P 500's +17% growth.

Stocks Performance
IRIX vs S&P 500

Loading...
IRIX
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
IRIX vs S&P 500

Performance Gap Between IRIX and GSPC
LOCKED
Unlock

Performance By Year
IRIX vs S&P 500

Loading...
IRIX
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
IRIDEX Corp vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

IRIDEX Corp
Glance View

Market Cap
15.6m USD
Industry
Health Care

IRIDEX Corp makes laser systems and related accessories used by eye doctors to treat retinal disease and glaucoma. Its products are sold mainly to ophthalmologists, hospitals, and outpatient eye clinics that use the equipment in procedures on patients with serious eye conditions. The company earns money by selling the laser consoles and the disposable or reusable parts that go with them, such as probes and treatment accessories. That mix matters because the installed system can lead to repeat sales of consumables, service, and replacement parts over time. IRIDEX sits in a specialized corner of the medical device market: it sells tools that help doctors perform eye procedures without replacing the doctor’s own clinical judgment or running a whole treatment center. Its business depends on the adoption of its systems in eye care practices and on the ongoing need for maintenance and procedure supplies.

IRIX Intrinsic Value
LOCKED
Unlock
Back to Top